Production of recombinant human growth hormone in Escherichia coli: expression of different precursors and physiological effects of glucose, acetate, and salts.
about
Characterisation of the Escherichia coli membrane structure and function during fedbatch cultivationThe acetate switch.Utilizing high-throughput experimentation to enhance specific productivity of an E.coli T7 expression system by phosphate limitation.Reducing conditions are the key for efficient production of active ribonuclease inhibitor in Escherichia coli.Proteins induced during adaptation of Acetobacter aceti to high acetate concentrations.Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.Improving the expression of recombinant proteins in E. coli BL21 (DE3) under acetate stress: an alkaline pH shift approach.Production of recombinant proteins in E. coli by the heat inducible expression system based on the phage lambda pL and/or pR promoters.The zero-sum game of pathway optimization: emerging paradigms for tuning gene expression.Recent advances in engineering the central carbon metabolism of industrially important bacteria.Expression, purification, and characterization of authentic mouse prolactin obtained in Escherichia coli periplasmic space.Mapping stress-induced changes in autoinducer AI-2 production in chemostat-cultivated Escherichia coli K-12.Expression of an anaplerotic enzyme, pyruvate carboxylase, improves recombinant protein production in Escherichia coliHybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study.Production of antibody fragments in Escherichia coli.Suppressing glucose uptake and acetic acid production increases membrane protein overexpression in Escherichia coli.Efficient feeding profile optimization for recombinant protein production using physiological information.Proteome analysis of the Escherichia coli heat shock response under steady-state conditionsExchange of single amino acids at different positions of a recombinant protein affects metabolic burden in Escherichia coli.Avoiding acetate accumulation in Escherichia coli cultures using feedback control of glucose feeding.Determination of the maximum specific uptake capacities for glucose and oxygen in glucose-limited fed-batch cultivations of Escherichia coli.Automatic inducer addition and harvesting of recombinant Escherichia coli cultures based on indirect on-line estimation of biomass concentration and specific growth rate.Acetate-inducible protein overexpression from the glnAp2 promoter of Escherichia coli.Metabolic adaptation of Escherichia coli during temperature-induced recombinant protein production: 1. Readjustment of metabolic enzyme synthesis.Limiting factors in Escherichia coli fed-batch production of recombinant proteins.Optimization of the extracellular production of a bacterial phytase with Escherichia coli by using different fed-batch fermentation strategies.Feed rate control in fed-batch fermentations based on frequency content analysis.Strain engineering to reduce acetate accumulation during microaerobic growth conditions in Escherichia coli.Very high-level production and export in Escherichia coli of a cellulose binding domain for use in a generic secretion-affinity fusion system.Process simulation for recombinant protein production: cost estimation and sensitivity analysis for heparinase I expressed in Escherichia coli.Physiological capacities decline during induced bioprocesses leading to substrate accumulation.Pilot-scale process development for low-cost production of a thermostable biodiesel refining enzyme in Escherichia coli.Mass production of thermostable D-hydantoinase by batch culture of recombinant Escherichia coli with a constitutive expression system.Feeding strategy design for recombinant human growth hormone production by Bacillus subtilis.Influence of bioreactor scale and complex medium on probing control of glucose feeding in cultivations of recombinant strains of Escherichia coli.Enhanced production of the nonribosomal peptide antibiotic valinomycin in Escherichia coli through small-scale high cell density fed-batch cultivation.Enhancing human-like collagen accumulation by deleting the major glucose transporter ptsG in recombinant Escherichia coli BL21.Optimizing recombinant protein production in the E. coli periplasm alleviates stress.Using small molecules as a new challenge to redirect metabolic pathway.Strategies in high-level expression of recombinant protein in Escherichia coli.
P2860
Q24800906-9895407E-A735-4A57-92D3-5F85DD4CC0D8Q33755202-AD8CF80E-B826-4D2C-8BD2-D7FA65BE35E5Q33849427-C0415E25-D13A-44BB-BAEC-3B23BC0A5DE1Q33893399-8C175580-DE2F-4862-A066-05F5C95FCEC0Q33990824-4D8289FB-53BF-4A1C-9882-17D09521D789Q34247760-819A29EA-1F91-40D2-8E62-F22D3896FEA6Q35427885-8E51C857-E950-4D43-80BC-3FA11A78CDEBQ37713994-DF30E0F4-B5FB-4EB2-81A3-556664DEF744Q37893112-126976F7-462E-49BD-AD27-18A0854B359DQ38006508-4B7C4E46-87B7-4E5C-AE0E-E648840B48E6Q39166308-8EC53DF9-FB3E-4B0E-B3B6-F934ADF1EE01Q39526449-50DF52AE-1858-45A5-A7C3-3AD9001556DBQ39661868-4525866A-C8F9-402B-A022-1396DAE6D145Q39995207-BB59AD79-7174-4BE8-8473-8810F4E7DF5CQ41003887-64B68690-B835-42E7-96CC-CFEA4A572A99Q42031883-784B960B-8C59-406F-BC9B-96DEC87F1964Q42426935-3C479F1A-B40A-4FCF-9011-FD946C2CDA75Q42579303-383FF840-8756-4C17-B70F-DE0B1C4DB000Q43120768-EE4E843A-33A2-4A38-91D5-28AA8EB685B9Q43547022-2AF872C3-FCE0-4BA3-9AC6-C9C7E6E48651Q43587179-D21B87A7-2C95-41FF-A813-CE16F332882FQ43759352-C2F60C05-F1AD-41F1-A574-741F5756A130Q43824183-32E0562D-E5A9-415E-A561-A2F65F2920EDQ44134222-8A69B271-3C81-4662-86AD-2467F6BF15D1Q44229041-B6977FA7-D83F-49A9-813A-70CCE28FDB7DQ44452254-F2361BBC-092E-42CB-B9CC-3C8B5617DE60Q45828535-A6C361C4-B64C-4E55-A439-B96CCC65567AQ46118282-B46C1A77-8D7D-40DC-A0A8-2F6214AB6451Q47445750-75689AE5-1B7E-40A2-BA44-EDEB746FEF86Q47862069-9FDB5CF5-4B8D-4CC8-91D9-2FA92FA1E1FDQ47996592-F22864BC-39BA-4FF9-811D-DB533D4C5C6AQ50098271-88B27C38-D134-43AC-BFCA-CC12FF297F21Q50457872-F61883BE-B733-4571-99C0-976D9C7F47B3Q50960610-3D278E55-BEE1-49A0-9F44-6B65CCEAD2C3Q51094635-7D3386A6-EF81-4878-88D6-24055E367820Q51758889-BDAF7BD6-1624-40E5-A258-B4E9270B0C0DQ51775627-91D65805-D1B9-4DCA-BC84-C8EDEECB001BQ52719509-7921666D-2B41-4EA2-ACC7-3D0CD7882FA6Q54298031-8329956F-0661-4EED-B32F-771CDF6E2AC3Q54633682-94A46F5A-098A-4F7E-8009-3342F303F39D
P2860
Production of recombinant human growth hormone in Escherichia coli: expression of different precursors and physiological effects of glucose, acetate, and salts.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Production of recombinant huma ...... f glucose, acetate, and salts.
@en
Production of recombinant huma ...... f glucose, acetate, and salts.
@nl
type
label
Production of recombinant huma ...... f glucose, acetate, and salts.
@en
Production of recombinant huma ...... f glucose, acetate, and salts.
@nl
prefLabel
Production of recombinant huma ...... f glucose, acetate, and salts.
@en
Production of recombinant huma ...... f glucose, acetate, and salts.
@nl
P356
P1476
Production of recombinant huma ...... f glucose, acetate, and salts.
@en
P2093
P356
10.1002/BIT.260360102
P577
1990-06-01T00:00:00Z